[1]
Gimeno-Mallench, L.; Sanchez-Morate, E.; Parejo-Pedrajas, S. The relationship between diet and frailty in aging. Endocr. Metab. Immune Disord. Drug Targets, 2020.
[http://dx.doi.org/10.2174/1871530320666200513083212] [PMID: 32400339]
[http://dx.doi.org/10.2174/1871530320666200513083212] [PMID: 32400339]
[2]
Jorda, A.; Campos-Campos, J.; Iradi, A. The role of Chemokines in Alzheimer’s disease. Endocr. Metab. Immune Disord. Drug Targets, 2020.
[http://dx.doi.org/10.2174/1871530320666200131110744]
[http://dx.doi.org/10.2174/1871530320666200131110744]
[3]
Navarro-Flores, E.; Cauli, O. Quality of life in individuals with diabetic foot syndrome. Endocr. Metab. Immune Disord. Drug Targets, 2020.
[http://dx.doi.org/10.2174/1871530320666200128154036]] [PMID: 32003676]
[http://dx.doi.org/10.2174/1871530320666200128154036]] [PMID: 32003676]
[4]
Magrone, T.; Magrone, M.; Russo, M.A.; Jirillo, E. Peripheral immunosenescence and central neuroinflammation: a dangerous liaison. A dietary approach. Endocr. Metab. Immune Disord. Drug Targets, 2020.
[http://dx.doi.org/10.2174/1871530320666200406123734 ] [PMID: 32250234]
[http://dx.doi.org/10.2174/1871530320666200406123734 ] [PMID: 32250234]
[5]
Buigues, C.; Queralt, A.; De Velasco, J.A.; Salvador-Sanz, A.; Jennings, C.; Wood, D.; Trapero, I. Lipid profile results after cardiovascular prevention programme: Euroaction model in Spain. Endocr. Metab. Immune Disord. Drug Targets, 2020, 20(9), 1412-1418.
[http://dx.doi.org/10.2174/1871530320666200610161344] [PMID: 32520696]
[http://dx.doi.org/10.2174/1871530320666200610161344] [PMID: 32520696]
[6]
Bodolea, C.; Hiriscau, E.I.; Buzdugan, E.C.; Grosu, A.I.; Stoicescu, L.; Vesa, Ș.; Cauli, O. The association between peripheral blood cells and the frailty syndrome in patients with cardiovascular diseases. Endocr. Metab. Immune Disord. Drug Targets, 2020, 20(9), 1419-1433.
[http://dx.doi.org/10.2174/1871530320666200813135905 ] [PMID: 32787768]
[http://dx.doi.org/10.2174/1871530320666200813135905 ] [PMID: 32787768]